“I don’t know
what I have.”

Get the answers you need with help from AVISE^®, the most advanced autoimmune testing available.

AVISE is designed to help rheumatologists more accurately diagnose lupus and other autoimmune connective tissue diseases. Powered by unique patented biomarkers and proprietary algorithm, the AVISE diagnostic tests like AVISE^® CTD (Connective Tissue Disease) and AVISE^® Lupus provide improved disease information compared to traditional lab tests alone.

AVISE^® CTD

Accurate and Early Diagnosis for Lupus and Connective Tissue Disease

Connective tissue diseases (CTDs) can be very hard to diagnose early because symptoms can be vague, inconsistent and/or attributed to other illnesses.

AVISE CTD combines AVISE Lupus, a 10-marker diagnostic test designed to help rule-in or rule-out lupus, with an expanded connective tissue disease panel to aid in the differential diagnosis of other connective tissue diseases.

When combined with your provider's clinical assessment, AVISE CTD can provide the information necessary to help make the right diagnosis. If you're ready to start dealing with the real cause of your symptoms don't wait. Request your AVISE CTD conversation guide to help you speak to your provider about the AVISE CTD test.

Request Information

Polymyositis is a disease that affects muscles all over the body. This autoimmune disease causes muscles to become irritated and inflamed, eventually causing them to break down and become weak.

Characterized by chronic muscle inflammation and weakness, Dermatomyositis is one of a group of diseases known as inflammatory myopathies. There is no cure for Dermatomyositis, but the symptoms of this disease can be treated.

Graves' disease is an autoimmune disease that leads to an overactivity of the thyroid gland. In the United States, it is the most common cause of hyperthyroidism. Symptoms vary and include weight loss, irregular heartbeat, muscle weakness, trouble tolerating heat and enlarged thyroid gland, called a goiter.

Hashimoto’s disease is an autoimmune disease that affects the thyroid gland. Over time, the thyroid’s ability to produce thyroid hormones becomes impaired and leads to a decline in function and eventually an underactive thyroid, known as hypothyroidism. Symptoms include weight gain, muscle and joint pain, trouble tolerating the cold, and slowed heart rate.

Who should be considered for the AVISE CTD test?

Patients who are
ANA+ referrals
Patients with clinical suspicion of a connective tissue disease
Patients with overlapping symptoms
ANA+ fibromyalgia patients suspected of autoimmune disease

Patented CB‑CAPs biomarkers

AVISE Lupus, a component of AVISE CTD, is the only validated test that uses patented biomarkers called CB-CAPs that have been proven to outperform standard diagnosis laboratory testing in the detection of SLE.

CB-CAPs identifies significantly more lupus patients that would otherwise appear negative with conventional markers. CB-CAPs are an innovative way to measure abnormality in your immune system that is unique to lupus.

Using CB-CAPs and other lupus-associated markers, AVISE CTD employs an advanced two-tier algorithm and proprietary Index Value to help turn isolated data points into actionable information. The index result is plotted on a spectrum associated with the likelihood of the presence of lupus.